NM@PLGA‐MTI‐OXA administration significantly reduced the number of colorectal tumor nodules, with an inhibition rate reaching 75.8% compared to Fn group, indicating substantial therapeutic efficacy. Here, FN1 is linked to colorectal neoplasm.